Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma
Clinical trial NCT03998033 · TERMINATED
Trial details
- NCT number
- NCT03998033
- Sponsor
- Eureka Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2020-12-31
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.